RecruitingNCT06925178

Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease


Sponsor

Beijing Tiantan Hospital

Enrollment

800 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to establish a multi-center and multi-modality imaging standard cohort of cerebrovascular disease, analyze the potential mechanisms affecting the prognosis of cerebrovascular disease based on a variety of imaging methods, and explore potential therapeutic targets.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This multicenter study is building a database of brain imaging data from patients who have experienced a stroke or brain bleed, with the goal of understanding what predicts recovery and identifying potential treatment targets. Researchers are collecting multiple types of imaging — including CT, MRI, and eye tests — from approximately 800 patients within 7 days of their stroke. Adults aged 18 to 80 who have had an ischemic or hemorrhagic stroke confirmed by brain imaging may be eligible, provided they can cooperate with the required tests and are expected to survive at least 3 months. Participation involves undergoing brain scans and follow-up assessments at 3, 6, and 12 months. This summary was prepared to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06925178


Related Trials